Geron Corporation (GERN)
NASDAQ: GERN · Real-Time Price · USD
1.500
-0.010 (-0.66%)
Apr 29, 2026, 9:58 AM EDT - Market open
Geron Employees
Geron had 258 employees as of December 31, 2025. The number of employees increased by 29 or 12.66% compared to the previous year.
Employees
258
Change (1Y)
29
Growth (1Y)
12.66%
Revenue / Employee
$712,717
Profits / Employee
-$323,643
Market Cap
961.35M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,300 |
| Maravai LifeSciences Holdings | 435 |
| Xeris Biopharma Holdings | 435 |
| Phathom Pharmaceuticals | 371 |
| KalVista Pharmaceuticals | 275 |
| Xencor | 260 |
| Janux Therapeutics | 109 |
| ORIC Pharmaceuticals | 104 |
GERN News
- 7 days ago - Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026 - GlobeNewsWire
- 8 days ago - Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 14 days ago - Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 15 days ago - Geron Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 16 days ago - Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary - GlobeNewsWire
- 23 days ago - Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Geron Announces Appointment of New Members to its Board of Directors - GlobeNewsWire
- 7 weeks ago - Geron Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts